Decipher Labs Ltd. is underperforming significantly compared to its peers in the Pharmaceuticals & Drugs industry, with negative growth, profitability, and efficiency metrics. The sector shows a mix of strong performers and financially stable companies, making Decipher Labs a clear outlier on the downside.

• • Decipher Labs shows negative revenue growth and profitability metrics, with a PE ratio of -23.81 indicating significant losses.
• • Sun Pharmaceutical Industries and Dr. Reddy's Laboratories are standout performers with high ROE, profitability, and positive growth.
• • Financially weak companies include Decipher Labs, which has low margins and negative earnings metrics.